Spironolactone marketed by Pfizer Laboratories Div Pfizer Inc under NDC Code 0025-1031-31
NDC Code(s) : 0025-1001-31, 0025-1041-31, 0025-1031-31
Packager : Pfizer Laboratories Div Pfizer Inc
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Aldactonespironolactone TABLET, FILM COATED |
|
|
|
|
|
|
Aldactonespironolactone TABLET, FILM COATED |
|
|
|
|
|
|
Aldactonespironolactone TABLET, FILM COATED |
|
|
|
|
|
|
PRINCIPAL DISPLAY PANEL
Pfizer
NDC 0025-1001-31
Aldactone®
(spironolactone)
tablets, USP
25 mg
100 Tablets
Rx only
![PRINCIPAL DISPLAY PANEL - 25 mg Tablet Bottle Label](/xml/0fed2822-3a03-4b64-9857-c682fcd462bc/aldactone-05.jpg)
PRINCIPAL DISPLAY PANEL
Pfizer
NDC 0025-1041-31
Aldactone®
(spironolactone)
tablets, USP
50 mg
100 Tablets
Rx only
![PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label](/xml/0fed2822-3a03-4b64-9857-c682fcd462bc/aldactone-06.jpg)
PRINCIPAL DISPLAY PANEL
Pfizer
NDC 0025-1031-31
Aldactone®
(spironolactone)
tablets, USP
100 mg
100 Tablets
Rx only
![PRINCIPAL DISPLAY PANEL - 100 mg Tablet Bottle Label](/xml/0fed2822-3a03-4b64-9857-c682fcd462bc/aldactone-07.jpg)
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.